Cures Within Reach funding opportunities that may be of interest to University of Illinois Cancer Center members.
2025 ReGRoW: Funding for Under-Resourced Researchers in Low and Lower-Middle Income Countries
- Application deadline: 03/28/2025
- Purpose: Cures Within Reach’s ReGRoW program provides up to $65,000 in funding for interventional human clinical trials led by researchers in low-to-middle-income countries (LMICs) that address high disease burden with a repurposed therapy to prevent disease progression and/or improve patient outcomes. Projects with US-based collaborators are allowable.
Repurposing Research for Chicago 2025
- Letter of Intent Deadline: 04/18/2025
- Purpose: Cures Within Reach invites proposals for clinical repurposing trials led by Chicago area PIs in one or more of the following tracks: health equity, early stage investigators, pediatrics, veterans/military in any disease area. Accepting budgets of up to $100,000, including a 20% institutional match (no indirect costs). For health disparities trials, CWR will provide $5,000 – $15,000 in additional financial support for approved community engagement costs, and this funding should be added to the requested funding amount submitted to CWR.
The University of Illinois Cancer Center has approval to pursue the following grant opportunities from foundations through its Advancement team. As a Cancer Center member, please notify and work with Jane Erb ([email protected]) and her Advancement team if you have an interest in any of the follow